Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
954 studies found for:    als
Show Display Options
Rank Status Study
1 Recruiting Genetics of Familial and Sporadic ALS
Conditions: Amyotrophic Lateral Sclerosis (ALS);   Familial Amyotrophic Lateral Sclerosis;   Amyotrophic Lateral Sclerosis With Frontotemporal Dementia;   Lou Gehrig's Disease;   Motor Neuron Disease;   Primary Lateral Sclerosis
Intervention: Other: Genetic study of ALS families
2 Completed Talampanel for Amyotrophic Lateral Sclerosis (ALS)
Condition: ALS
Interventions: Drug: Talampanel;   Other: placebo
3 Recruiting Imaging and BioFluid Biomarkers in Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis (ALS)
Intervention: Drug: [18F] GE-180
4 Enrolling by invitation Biological Treatment of Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis
Interventions: Other: Biological: Cell-based therapeutics;   Other: Symptomatic treatment of ALS
5 Completed Clinical Trial of SB-509 in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis
Intervention: Drug: SB-509
6 Recruiting ALS Testing Through Home-based Outcome Measures
Condition: Amyotrophic Lateral Sclerosis
Intervention: Other: Respirometer, Handgrip Meter, Skulpt Chisel, ActigraphyMeter
7 Completed
Has Results
A Clinical Demonstration of EEG Brain-computer Interface for ALS Patients
Condition: ALS (Amyotrophic Lateral Sclerosis)
Intervention: Device: BCI Device
8 Completed Validation of Biomarkers in Amyotrophic Lateral Sclerosis (ALS)
Conditions: Amyotrophic Lateral Sclerosis;   Lou Gehrig's Disease;   Primary Lateral Sclerosis;   Nervous System Diseases;   Hereditary Spastic Paraparesis
Intervention: Other: No intervention
9 Recruiting Assessment of Voluntary and Reflex Cough in Patients With ALS
Conditions: ALS;   Cough
Intervention: Other: Cough Assessment in ALS Patients
10 Active, not recruiting Ibudilast (MN-166) in Subjects With Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis
Interventions: Drug: Placebo (for MN-166);   Drug: MN-166
11 Recruiting PRE-Symptomatic Studies in ALS
Condition: Amyotrophic Lateral Sclerosis
Intervention:
12 Completed National Registry of Veterans With Amyotrophic Lateral Sclerosis and DNA Bank
Condition: ALS
Intervention:
13 Active, not recruiting Human Spinal Cord Derived Neural Stem Cell Transplantation for the Treatment of Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis
Intervention: Device: surgical implantation
14 Completed Muscle Ultrasound: A New Tool for Measuring Progression in Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis
Intervention:
15 Enrolling by invitation A Study for Patients Who Completed VITALITY-ALS (CY 4031)
Condition: Amyotrophic Lateral Sclerosis (ALS)
Intervention: Drug: tirasemtiv
16 Recruiting Amyotrophic Lateral Sclerosis: a New Paradigm
Condition: Amyotrophic Lateral Sclerosis
Intervention: Other: study ALS patients
17 Active, not recruiting Diaphragm Pacing System (DPS) In Participants With Amyotrophic Lateral Sclerosis (ALS)
Condition: Amyotrophic Lateral Sclerosis (ALS)
Intervention: Device: NeuRx® Diaphragm Pacing System™ (DPS)
18 Completed Phase II Study Using Thalidomide for the Treatment of ALS
Conditions: Amyotrophic Lateral Sclerosis;   ALS
Intervention: Drug: Thalidomide
19 Suspended Safety/Efficacy Study for the Treatment of Amyotrophic Lateral Sclerosis
Condition: Amyotrophic Lateral Sclerosis
Intervention: Biological: autologous bone marrow-derived stem cells
20 Unknown  Safety, Tolerability, and Preliminary Efficacy Study of ALS-357 in Patients With Cutaneous Metastatic Melanoma
Condition: Melanoma
Intervention: Drug: ALS-357

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.